Literature DB >> 11145790

Cellular and immunologic mechanisms in atopic dermatitis.

D Y Leung1, N A Soter.   

Abstract

Atopic dermatitis is a chronic inflammatory skin disease that is frequently associated with respiratory allergies. Atopic dermatitis develops as a result of a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors. Efforts to understand the relative contributions of these factors have led to research seeking to identify the relevant effector cells and mediators involved in the pathogenesis of atopic dermatitis. These factors include the pattern of local cytokine release, the differentiation of helper T cells, multiple roles of IgE, skin-directed cell responses, infectious agents, and superantigens. This article reviews these cellular and immunologic mechanisms underlying atopic dermatitis and discusses how an understanding of their role in the inflammatory process may lead to improved treatments for atopic dermatitis.

Entities:  

Mesh:

Year:  2001        PMID: 11145790     DOI: 10.1067/mjd.2001.109815

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  29 in total

1.  Tacrolimus ointment: advancing the treatment of atopic dermatitis.

Authors:  V S Beltrani
Journal:  Curr Allergy Asthma Rep       Date:  2001-07       Impact factor: 4.806

2.  Oral administration of poly-γ-glutamate ameliorates atopic dermatitis in Nc/Nga mice by suppressing Th2-biased immune response and production of IL-17A.

Authors:  Tae-Young Lee; Doo-Jin Kim; Ji-Na Won; Il-Han Lee; Moon-Hee Sung; Haryoung Poo
Journal:  J Invest Dermatol       Date:  2013-09-11       Impact factor: 8.551

Review 3.  The economics of topical immunomodulators for the treatment of atopic dermatitis.

Authors:  William Abramovits; Mark Boguniewicz; Amy S Paller; Diane L Whitaker-Worth; Mary M Prendergast; Michael Tokar; Kuo B Tong
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Phase-dependent roles of E-selectin during chronic contact hypersensitivity responses.

Authors:  Tomoyuki Fujita; Manabu Fujimoto; Takashi Matsushita; Yuka Shimada; Minoru Hasegawa; Yoshihiro Kuwano; Fumihide Ogawa; Kazuhiko Takehara; Shinichi Sato
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 5.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms.

Authors:  Peter M Elias; Yutaka Hatano; Mary L Williams
Journal:  J Allergy Clin Immunol       Date:  2008-03-07       Impact factor: 10.793

6.  Blood rheological properties in patients with atopic dermatitis (AD).

Authors:  A Kasperska-Zajac; Z Brzoza; E Koczy-Baron; J Jagodzinska; L Slowinska; B Rogala
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

7.  Impaired Junctions and Invaded Macrophages in Oral Epithelia With Oral Pain.

Authors:  Reiko U Yoshimoto; Reona Aijima; Yukiko Ohyama; Junko Yoshizumi; Tomoko Kitsuki; Yasuyoshi Ohsaki; Ai-Lin Cao; Atsushi Danjo; Yoshio Yamashita; Tamotsu Kiyoshima; Mizuho A Kido
Journal:  J Histochem Cytochem       Date:  2018-11-19       Impact factor: 2.479

Review 8.  Skin barrier function.

Authors:  Peter M Elias
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

Review 9.  Atopic dermatitis and fungi.

Authors:  Jan Faergemann
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

10.  Inhibition of Chitinase-3-like-1 by K284-6111 Reduces Atopic Skin Inflammation via Repressing Lactoferrin.

Authors:  Seong Hee Jeon; Yong Sun Lee; In Jun Yeo; Hee Pom Lee; Jaesuk Yoon; Dong Ju Son; Sang-Bae Han; Jin Tae Hong
Journal:  Immune Netw       Date:  2021-06-29       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.